FIELD: chemistry.
SUBSTANCE: invention relates to pharmaceutically suitable salts which are given in claim 1. The invention also relates to medicinal agents based on the said compounds, which are HSP90 inhibitors.
EFFECT: novel compounds and medicinal agents based on said compounds are obtained, which can be used to treat diseases influenced by inhibition, regulation or modulation of HSP90.
3 cl, 1 tbl, 16 ex
| Title | Year | Author | Number |
|---|---|---|---|
| TRIAZOLE DERIVATIVES | 2006 |
|
RU2416605C2 |
| FURO[3,2-B]- AND THIENO[3,2-B]PYRIDINE DERIVATIVES AS TBK1 AND IKKε INHIBITORS | 2013 |
|
RU2622034C2 |
| 2-AMINO-4-PHENYLAZOLINE DERIVATIVES AND USE THEREOF AS HSP90 MODULATORS | 2006 |
|
RU2421449C2 |
| 2-CARBOXAMIDE CYCLOAMINO UREA DERIVATIVES IN COMBINATION WITH HSP90 INHIBITORS FOR TREATING PROLIFERATIVE DISEASES | 2012 |
|
RU2624493C2 |
| INHIBITORS OF EPIDERMAL GROWTH FACTOR RECEPTOR | 2018 |
|
RU2786524C2 |
| EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS | 2022 |
|
RU2821531C2 |
| PHARMACEUTICAL COMBINATIONS CONTAINING PYRIDO[4,3-d]PYRIMIDINE DERIVATIVES AS HSP90 INHIBITOR AND HER2 INHIBITOR | 2009 |
|
RU2532375C2 |
| HYDRAZONO-MALONITRILES | 2002 |
|
RU2302412C2 |
| METHODS AND MEDICAL APPLICATIONS | 2018 |
|
RU2788174C2 |
| NEW ISOINDOLE DERIVATIVES, COMPOSITIONS CONTAINING THEREOF, PRODUCTION AND PHARMACEUTICAL APPLICATION THEREOF, PARTICULARLY AS INHIBITORS OF CHAPERONE PROTEIN Hsp90 ACTIVITY | 2006 |
|
RU2375361C2 |
